Please assess the completion status of the following clinical trial:

Trial Title: Nicotinic Receptor Augmentation of SSRI Antidepressants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Major depression, recurrent outpatients, ages 18-65, smoker or non-smoker, on SSRI monotherapy, depression scores on HDRS-17 item scale or = 12.~Exclusion Criteria:~* suicidal or homicidal ideation, need for inpatient or partial hospital care, systolic blood pressure \<100 mm Hg, history of hypersensitivity to mecamylamine or its excipients.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).